Delivery Order SPE2DB22D3501-SPE2DB24FUU37
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $4,393.65, is for the delivery of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,100.48 firm-fixed-price contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a completion date of July 29, 2024 and was awarded on July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- This is a $8,023.13 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 150ML" and has a completion date of May 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a completion date of February 6, 2024 and a potential value of $4,973.22. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,530.00, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen Drug Corp is a for-profit organization that holds several Indefinite...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a completion date of February 28, 2024 and a potential value of $2,142.00. The contract does not have a set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has a firm fixed-price of $3,612.42 and a completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a $1,998.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (150 mL). This competitive award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension (150 mL) with a ceiling value of $1,020.18. This is a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively issued with no set-aside designation and represents a child contract under...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, with a ceiling value of $1,332.16 and a period of performance through July 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUU37Delivery Order
This is a firm fixed price delivery order for $1,020.00 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a range of pharmaceutical products and medical supplies in support of military treatment programs and facilities. This delivery order is placed against that IDC, which does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor, delivering these critical pharmaceutical products and supporting medical materials directly to DLA Troop Support facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/1/24 |